pentylenetetrazole has been researched along with Pancreatic Diseases in 1 studies
Pentylenetetrazole: A pharmaceutical agent that displays activity as a central nervous system and respiratory stimulant. It is considered a non-competitive GAMMA-AMINOBUTYRIC ACID antagonist. Pentylenetetrazole has been used experimentally to study seizure phenomenon and to identify pharmaceuticals that may control seizure susceptibility.
pentetrazol : An organic heterobicyclic compound that is 1H-tetrazole in which the hydrogens at positions 1 and 5 are replaced by a pentane-1,5-diyl group. A central and respiratory stimulant, it was formerly used for the treatment of cough and other respiratory tract disorders, cardiovascular disorders including hypotension, and pruritis.
Pancreatic Diseases: Pathological processes of the PANCREAS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| BARTA, L | 1 |
| VEDRESNE TOTH, M | 1 |
1 other study available for pentylenetetrazole and Pancreatic Diseases
| Article | Year |
|---|---|
[Changes in the blood sugar level after Metrazol administration during starvation].
Topics: Blood Glucose; Humans; Hypoglycemia; Pancreatic Diseases; Pentylenetetrazole; Starvation | 1962 |